WBR0462: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{WBRQuestion |QuestionAuthor={{Rim}} |ExamType=USMLE Step 1 |MainCategory=Pharmacology |SubCategory=Cardiology |MainCategory=Pharmacology |SubCategory=Cardiology |MainCategor...")
 
No edit summary
Line 20: Line 20:
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Cardiology
|SubCategory=Cardiology
|Prompt=A 62 year old patient presents to the physician’s office for abnormal vision.  The patient explains that he is seeing yellow-green halos since a new drug has been prescribed.  The patient’s past medical history is significant for latent tuberculosis, cardiac disease, and erectile dysfunction. The physician suspects the patient’s vision problems are a side effect of a medication he is taking.  Which of the following medication is the most likely cause of this patient’s symptoms?
|Prompt=A 62-year-old male presents to the physician’s office with complaints of  abnormal vision.  The patient explains that he has been seeing yellow-green halos beginning upon the administration of a new drug.  The patient’s past medical history is significant for latent tuberculosis, cardiac disease, and erectile dysfunction. Which of the following medications is most likely the cause of this patient’s symptoms?
|Explanation=[[Digitalis]] is a direct [[Na/K/ATPase inhibitor]] that indirectly inhibits the [[Na/Ca exchanger]] by inhibiting the Na gradient that essentially plays a role in activating the exchanger.  As a result, intracellular Ca increases and inotropy thus increased.  [[Digitalis]] also has [[cholinomimetic]] effects due to its vagal activation that increases [[PR interval]], delays [[AV node]] conduction, and decreases [[QT interval]].  [[Digitalis]] is commonly used in patients with [[congestive heart failure]]. [[Side effects]] of [[digitalis]] include change in vision color that is typically a green-yellow visual disturbance, as in the patient in the vignette.  
|Explanation=[[Digitalis]] is a direct [[Na/K/ATPase inhibitor]] that indirectly inhibits the [[Na/Ca exchanger]] by inhibiting the Na gradient that essentially plays a role in activating the exchanger.  As a result, intracellular Ca increases and inotropy thus increased.  [[Digitalis]] also has [[cholinomimetic]] effects due to its vagal activation that increases [[PR interval]], delays [[AV node]] conduction, and decreases [[QT interval]].  [[Digitalis]] is commonly used in patients with [[congestive heart failure]]. [[Side effects]] of [[digitalis]] include change in vision color that is typically a green-yellow visual disturbance, as in the patient in the vignette.  



Revision as of 14:16, 24 July 2014

 
Author [[PageAuthor::Rim Halaby, M.D. [1]]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Pharmacology
Sub Category SubCategory::Cardiology
Prompt [[Prompt::A 62-year-old male presents to the physician’s office with complaints of abnormal vision. The patient explains that he has been seeing yellow-green halos beginning upon the administration of a new drug. The patient’s past medical history is significant for latent tuberculosis, cardiac disease, and erectile dysfunction. Which of the following medications is most likely the cause of this patient’s symptoms?]]
Answer A AnswerA::Sildenafil
Answer A Explanation AnswerAExp::Sildenafil is a phosphodiesterase (PDE) 5 inhibitor that maintains elevated cGMP and nitrous oxide (NO) levels. It is called the “blue pill” because of its color. Similarly, it causes a blue vision, not a green-yellow visual disturbance.
Answer B AnswerB::Tadalafil
Answer B Explanation AnswerBExp::Tadalafil, is a long-acting PDE 5 inhibitor. Although it might also cause a blue vision similar to sildenafil, it is not classically associated with visual color changes.
Answer C AnswerC::Digitalis
Answer C Explanation AnswerCExp::Digitalis causes a green-yellow color changes as seen in this patient.
Answer D AnswerD::Ethambutol
Answer D Explanation [[AnswerDExp::Ethambutol is an anti-tuberculous agent that causes green-red visual changes and optic neuritis, both of which are reversible after discontinuation of the medication. In addition, ethambutol is not given in latent tuberculosis (TB), as in this patient. It is an antibiotic that is given in active TB.]]
Answer E AnswerE::Rifampin
Answer E Explanation [[AnswerEExp::Rifampin is not associated with visual color changes. It is, however, associated with urine color changes into an orange color that has no clinical significance and self-resolves. Rifampin is also used in active TB, not latent TB as described in this patient.]]
Right Answer RightAnswer::C
Explanation [[Explanation::Digitalis is a direct Na/K/ATPase inhibitor that indirectly inhibits the Na/Ca exchanger by inhibiting the Na gradient that essentially plays a role in activating the exchanger. As a result, intracellular Ca increases and inotropy thus increased. Digitalis also has cholinomimetic effects due to its vagal activation that increases PR interval, delays AV node conduction, and decreases QT interval. Digitalis is commonly used in patients with congestive heart failure. Side effects of digitalis include change in vision color that is typically a green-yellow visual disturbance, as in the patient in the vignette.

Educational Objective: Digitalis is a positive inotropic agent that acts as a direct Na/K/ATPase inhibitor and is used in congestive heart failure. Digitalis is associated with green-yellow color changes.
Educational Objective:
References: ]]

Approved Approved::No
Keyword WBRKeyword::digitalis, WBRKeyword::vision, WBRKeyword::change, WBRKeyword::color, WBRKeyword::disturbance, WBRKeyword::sildenafil, WBRKeyword::tadalafiil, WBRKeyword::ethambutol, WBRKeyword::side, WBRKeyword::effect, WBRKeyword::adverse, WBRKeyword::drug, WBRKeyword::reaction
Linked Question Linked::
Order in Linked Questions LinkedOrder::